Afatinib/gefitinib/osimertinibAcquired resistance: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1806卷 / 1期

关键词：

D O I：

10.1007/s40278-020-79039-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：21 / 21

相关论文

共 50 条

[41] OsimertinibAcquired resistance: case report
Reactions Weekly, 2019, 1762 (1) : 283 - 283
[42] OsimertinibAcquired resistance: case report
Reactions Weekly, 2020, 1821 (1) : 202 - 202
[43] Gefitinib/icotinibLack of efficacy: 4 case reports
Reactions Weekly, 2022, 1918 (1) : 240 - 240
[44] Erlotinib/osimertinibAcquired resistance: case report
Reactions Weekly, 2021, 1880 (1) : 179 - 179
[45] Dacomitinib/gefitinib/osimertinibDrug resistance: 2 case reports
Reactions Weekly, 2022, 1901 (1) : 192 - 192
[46] Afatinib/erlotinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1696 (1) : 18 - 18
[47] OsimertinibAcquired drug resistance : case report
Reactions Weekly, 2025, 2047 (1) : 363 - 363
[48] OsimertinibAcquired drug resistance: case report
Reactions Weekly, 2024, 2022 (1) : 222 - 222
[49] Erlotinib/osimertinibAcquired resistance: case report
Reactions Weekly, 2022, 1916 (1) : 198 - 198
[50] OsimertinibAcquired drug resistance: case report
Reactions Weekly, 2019, 1769 (1) : 336 - 336

← 1 2 3 4 5 →